BridgeBio Oncology Therapeutics, Inc. (BBOT) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-22 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-29 | 8-K | Officer / Director Changes | SEC |
| 2026-04-23 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-26 | 8-K | Officer / Director Changes | SEC |
| 2026-03-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-13 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-06 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-04 | 8-K | Shareholder Vote Results | SEC |
| 2025-07-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-03 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-02-28 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-10 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-02-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-14 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.